Testing effectiveness (Phase 2)Study completedNCT01196871
What this trial is testing
Drug-Drug Interaction Study Between AT1001 (Migalastat Hydrochloride) and Agalsidase in Participants With Fabry Disease
Who this might be right for
Fabry Disease
Amicus Therapeutics 20